Recombinant GLP-1 receptor agonists (Beijing Lepu)

Primary objective: To compare the similarity of the pharmacokinetic characteristics of the test drug and the reference drug in Chinese healthy subjects after a single dose of the recombinant GLP-1 receptor agonist injection produced by Beijing Lepu Pharmaceutical Technology Co., Ltd. as the test drug and the dulaglutide injection (trade name: TRULICITY ® ) produced by Vetter Pharma-Fertigung GmbH & Co.KG as the reference drug. Secondary objective: To compare the safety and immunogenicity of the test drug and the reference drug after a single subcutaneous injection in Chinese healthy subjects.